Publications by authors named "Michael Detke"

Claim this Profile
M
Measures of outcome for stimulant trials: ACTTION recommendations and research agenda.
Brian D Kiluk, Kathleen M Carroll, Amy Duhig, Daniel E Falk, Kyle Kampman, Michael J Detke

Drug Alcohol Depend· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of Site-Based Versus Central Ratings in a Study of Generalized Anxiety Disorder.
Janet B W Williams, Kenneth A Kobak, Earl Giller, David S Reasner, Lisa Curry, Michael J Detke

J Clin Psychopharmacol· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A 6-week randomized, double-blind, placebo-controlled, comparator referenced trial of vabicaserin in acute schizophrenia.
Joan H Q Shen, Yonggang Zhao, Sharon Rosenzweig-Lipson, Danielle Popp, Janet B W Williams, Michael J Detke

J Psychiatr Res· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of duloxetine on norepinephrine and serotonin transporter activity in healthy subjects.
Jill C Chappell, Graeme Eisenhofer, Michael J Owens, Harry Haber, D Richard Lachno, Michael J Detke

J Clin Psychopharmacol· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of the effects of duloxetine and escitalopram on 24-hour heart rate variability: a mechanistic study using heart rate variability as a pharmacodynamic measure.
Jill C Chappell, Richard Kovacs, Harry Haber, Ryan Wright, Malcolm I Mitchell, Michael Detke

J Clin Psychopharmacol· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of duloxetine for the treatment of generalized anxiety disorder: implications for primary care physicians.
Hannu Koponen, Christer Allgulander, Janelle Erickson, Eduardo Dunayevich, Yili Pritchett, Michael J Detke

Prim Care Companion J Clin Psychiatry· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sexual function during long-term duloxetine treatment in patients with recurrent major depressive disorder.
Angel-Luis Montejo, David G S Perahia, Melissa E Spann, Fujun Wang, Daniel J Walker, Michael J Detke

J Sex Med· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term safety of duloxetine during open-label compassionate use treatment of patients who completed previous duloxetine clinical trials.
Beth A Pangallo, Qi Zhang, Durisala Desaiah, David G S Perahia, Michael J Detke

Curr Med Res Opin· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term safety, tolerability, and efficacy of duloxetine in the treatment of fibromyalgia.
Philip J Mease, I Jon Russell, Daniel K Kajdasz, Curtis G Wiltse, Michael J Detke

Semin Arthritis Rheum· June 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of duloxetine in patients with chronic low back pain.
Vladimir Skljarevski, Durisala Desaiah, Hong Liu-Seifert, Qi Zhang, Amy S Chappell, Michael J Detke

Spine (Phila Pa 1976)· June 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluating the maintenance of effect of duloxetine in patients with diabetic peripheral neuropathic pain.
Vladimir Skljarevski, Durisala Desaiah, Qi Zhang, Amy S Chappell, Michael J Detke

Diabetes Metab Res Rev· October 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Duloxetine in the prevention of depressive recurrences: a randomized, double-blind, placebo-controlled trial.
David G S Perahia, Giuseppe Maina, Michael E Thase, Melissa E Spann, Fujun Wang, Michael J Detke

J Clin Psychiatry· May 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The relationship between antidepressant and analgesic responses: findings from six placebo-controlled trials assessing the efficacy of duloxetine in patients with major depressive disorder.
David A Fishbain, Michael J Detke, Joachim Wernicke, Amy S Chappell, Daniel K Kajdasz

Curr Med Res Opin· November 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A six-month double-blind, placebo-controlled, randomized clinical trial of duloxetine for the treatment of fibromyalgia.
Amy S Chappell, Laurence A Bradley, Curtis Wiltse, Michael J Detke, Deborah N D'Souza

Int J Gen Med· November 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Examining quality of life in patients with generalized anxiety disorder: clinical relevance and response to duloxetine treatment.
Mark H Pollack, Jean Endicott, Michael Liebowitz, James Russell, Michael Detke

J Psychiatr Res· October 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Duloxetine treatment for relapse prevention in adults with generalized anxiety disorder: a double-blind placebo-controlled trial.
Jonathan R T Davidson, Hans-Ulrich Wittchen, Pierre-Michel Llorca, Janelle Erickson, Michael Detke

Eur Neuropsychopharmacol· September 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized, double-blind study of increasing or maintaining duloxetine dose in patients without remission of major depressive disorder after initial duloxetine therapy.
Susan G Kornstein, David L Dunner, Adam L Meyers, Virgil G Whitmyer, Craig H Mallinckrodt, Michael J Detke

J Clin Psychiatry· September 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of duloxetine for treatment of fibromyalgia in patients with or without major depressive disorder: Results from a 6-month, randomized, double-blind, placebo-controlled, fixed-dose trial.
Jon I Russell, Philip J Mease, Timothy R Smith, Daniel K Kajdasz, Madelaine M Wohlreich, Michael J Detke

Pain· June 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical evidence for serotonin and norepinephrine reuptake inhibition of duloxetine.
Madhukar H Trivedi, Durisala Desaiah, Melissa J Ossanna, Yili L Pritchett, Stephen K Brannan, Michael J Detke

Int Clin Psychopharmacol· May 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differential antidepressant symptom efficacy: placebo-controlled comparisons of duloxetine and SSRIs (fluoxetine, paroxetine, escitalopram).
Craig H Mallinckrodt, Apurva Prakash, John P Houston, Ralph Swindle, Michael J Detke

Neuropsychobiology· April 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of duloxetine and selective serotonin reuptake inhibitors: comparisons as assessed by remission rates in patients with major depressive disorder.
Michael E Thase, Yili Lu Pritchett, Melissa J Ossanna, Ralph W Swindle, Jimmy Xu, Michael J Detke

J Clin Psychopharmacol· December 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evidence for the efficacy of duloxetine in treating mild, moderate, and severe depression.
Richard C Shelton, Anne C Andorn, Craig H Mallinckrodt, Madelaine M Wohlreich, Joel Raskin, Michael J Detke

Int Clin Psychopharmacol· November 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Simple options for improving signal detection in antidepressant clinical trials.
Craig H Mallinckrodt, Adam L Meyers, Apurva Prakash, Douglas E Faries, Michael J Detke

Psychopharmacol Bull· September 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Duloxetine in the treatment of major depressive disorder: an open-label study.
James I Hudson, David G Perahia, Inmaculada Gilaberte, Fujun Wang, John G Watkin, Michael J Detke

BMC Psychiatry· August 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Duloxetine treatment for role functioning improvement in generalized anxiety disorder: three independent studies.
Jean Endicott, James M Russell, Joel Raskin, Michael J Detke, Janelle Erickson

J Clin Psychiatry· April 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis